RISE UP for breast cancer 2024: conference highlights & takeaways

RISE UP (Revolutionizing Investigations to StEp Up Prevention) for breast cancer brought together leading cancer specialists, women's health providers, basic and population scientists, regulators, politicians, industry leaders, patient advocates, and more from around the world to discuss and chart a radical rethinking of breast cancer prevention and risk reduction through a lens of hormonal management across a woman's life course. The presentations at RISE UP were organized to outline a path forward by leveraging what we know about breast cancer biology, early detection, treatment, and endocrine therapy toward a better and sustainable approach for breast cancer prevention. Important conference considerations were to expand our thinking about prevention by broadly considering how the hormonal environment during different life phases or common benign conditions could be better managed to minimize breast cancer risk. This set the stage for transitioning to advances in risk prediction, promising risk-reducing agents, and biomarker-driven trials to test them. Biomarker-based trials discussed focused on 1) lower or intermittent doses of standard prevention agents, 2) drugs already approved for other health purposes, and 3) maximizing benefits from lifestyle interventions alone or in combination. Throughout RISE UP, there was a strong focus on promoting health equity, including comprehensive reproductive health access, equitable representation in clinical trials, and strategies to educate women, providers, and advocates about disparities in care and how to successfully reduce them. The meeting concluded with a competition for innovative approaches to breast cancer prevention that could be integrated into hormonal and women's health interventions. RISE UP was an innovative conference that provided a forum for cross-cutting topics in women's health that do not currently exist. The insights shared at RISE UP will be paradigm shifting in breast cancer prevention and women's health space in the years to come.

Authors

Institutions

Publication Details

Journal
Breast Cancer Research and Treatment
Published
2026-01-01
DOI
https://doi.org/10.1007/s10549-025-07848-7
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

RISE UP for breast cancer 2024: conference highlights & takeaways

S. Formenti, Daniel Grossman, L J Esserman, Laura van ‘t Veer et al.
Breast Cancer Research and Treatment
BRCA gene mutations in cancer
article

RISE UP for breast cancer 2024: conference highlights & takeaways

S. Formenti, Daniel Grossman, L J Esserman, Laura van ‘t Veer, Nitin Seth, Diane Heditsian, Andrea V. Jackson, N Hylton, Kim F. Rhoads, Douglas Yee, Charlene Fabian, Virginia Borges, Katherine Leggat-Barr, Elissa R. Price, Laura Fejerman, L. Pusztai, Hope S. Rugo, Adetunji T. Toriola, Sara Horton, Elizabeth Garner, Andrea De Censi, Carol A Lange, Olufunmilayo Olopade, Taylor Glatt, Judy Garber
article en

Abstract

RISE UP (Revolutionizing Investigations to StEp Up Prevention) for breast cancer brought together leading cancer specialists, women's health providers, basic and population scientists, regulators, politicians, industry leaders, patient advocates, and more from around the world to discuss and chart a radical rethinking of breast cancer prevention and risk reduction through a lens of hormonal management across a woman's life course. The presentations at RISE UP were organized to outline a path forward by leveraging what we know about breast cancer biology, early detection, treatment, and endocrine therapy toward a better and sustainable approach for breast cancer prevention. Important conference considerations were to expand our thinking about prevention by broadly considering how the hormonal environment during different life phases or common benign conditions could be better managed to minimize breast cancer risk. This set the stage for transitioning to advances in risk prediction, promising risk-reducing agents, and biomarker-driven trials to test them. Biomarker-based trials discussed focused on 1) lower or intermittent doses of standard prevention agents, 2) drugs already approved for other health purposes, and 3) maximizing benefits from lifestyle interventions alone or in combination. Throughout RISE UP, there was a strong focus on promoting health equity, including comprehensive reproductive health access, equitable representation in clinical trials, and strategies to educate women, providers, and advocates about disparities in care and how to successfully reduce them. The meeting concluded with a competition for innovative approaches to breast cancer prevention that could be integrated into hormonal and women's health interventions. RISE UP was an innovative conference that provided a forum for cross-cutting topics in women's health that do not currently exist. The insights shared at RISE UP will be paradigm shifting in breast cancer prevention and women's health space in the years to come.

Breast Cancer Research and TreatmentVol. 215(2)
Tufts University (US), University of California, San Francisco (US), Washington University in St. Louis (US), Cornell University (US), American Association of University Women (US), Yale Cancer Center (US), Ente Ospedaliero Ospedali Galliera (IT), Yale University (US), University of Chicago (US), Quantum Leap Healthcare Collaborative (US), City of Hope (US), Dana-Farber Cancer Institute (US), University of Kansas Medical Center (US), University of Minnesota Medical Center (US), Cancer Genetics (United States) (US), UC Davis Comprehensive Cancer Center, University of Colorado Anschutz Medical Campus (US), University of California, Davis (US)
National Institutes of Health
Openalex Percentile: Top 95%
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.